Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day August Micro-Cap Conference taking place Wednesday and Thursday, August 17-18, 2022. The links can also be found at www.sidoticonference.com/events.
| |||
Presentation Agenda | |||
Wednesday, August 17th, 2022 (Day 1) | |||
8:30-9:00 | |||
9:15-9:45 | |||
10:00-10:30 | ***** | ||
10:45-11:15 | |||
11:30-12:00 | |||
12:15-12:45 | |||
1:00-1:30 | |||
1:45-2:15 | |||
2:30-3:00 | ***** | ||
3:15-3:45 | ***** | ||
4:00-4:30 | ***** | ||
1x1s Only | Gulf Island Fabrication (GIFI) | Kelly Services (KELYA) | |
| |||
Thursday, August 18th, 2022 (Day 2) | |||
9:15-9:45 | |||
10:00-10:30 | |||
10:45-11:15 | |||
11:30-12:00 | |||
12:15-12:45 | |||
1:00-1:30 | |||
1x1s Only | American Woodmark (AMWD) | Paysign, Inc. (PAYS | Wireless Telecom Group (WTT) |
About Sidoti
For over two decades, Sidoti has been a premier provider of independent securities research focused specifically on Small Cap and Micro-Cap companies and the institutions that invest their securities, with most of our coverage in the $50 million to $3 billion market cap range. Our approach affords companies and institutional clients a combination of high-quality research, a Small Cap and Micro-Cap focused nationwide sales effort, and broad access to corporate management teams. We serve 500+ institutional clients in the U.S. and Canada, including many leading institutional managers. Sidoti promotes meaningful interaction between issuers and investors in the Small Cap and Micro-Cap space through a series of investor conferences (www.sidoti.com/events) we host each year.
CONTACT
Sidoti Events Team
212-453-7031
This email address is being protected from spambots. You need JavaScript enabled to view it.
| Last Trade: | US$2.92 |
| Daily Change: | -0.20 -6.41 |
| Daily Volume: | 3,308 |
| Market Cap: | US$75.720M |
February 13, 2024 November 14, 2023 October 06, 2023 October 06, 2023 September 20, 2023 | |
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORE
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MORE
